Glaucoma is the ultimate commonly acquired optic neuropathy. It signifies a public health challenge since it causes an irreversible blindness. The single known treatment of the disease is decreasing of intraocular pressure (IOP), which has been revealed to lessen and acceleration of the aqueous humour outflow. In conclusion, RAS modulators have an imperious role in lowering IOP, these compounds will pave the approach for prospect innovation, improvement, and publicizing of novel drugs to treat glaucoma and therefore, aid save vision for millions of people suffering with this slow progressive optic neuropathy.
Introduction
The eye is a sensory organ that mainly captures light and offers the sense of vision, as well as transporting non-visual light data encompassing biological rhythms and neurophysiological actions to the brain 1 . There are diverse categories of optical diseases were recognized in a human eye. Most of them arise in the retina, which comprises from epithelium cells (pigmented type), glia, neuron as well as blood vessels Glaucoma is next to cataract as a main reason of blindness globally. It represents an even more public health problem than cataracts as the loss of sight it reasons is permanent 5 .In 2020, 80 million people are predicted to be investigated with glaucoma, which is expected to affect more than 11 million cases of consensual blindness 6 . This amount is probably to be even more owing to the aspect that glaucoma can be asymptomatic for a extended period which makes it problematic to recognize till it is complicated 7 .
Glaucoma reflect a multi-factorial and chronic neurodegenerative condition, which could be defined via the nonapoptotic and apoptotic loss of retinal ganglion cells ( RGC) and the damage of retinal nerve fibers that subsequently result However, the most important typical reason of the glaucoma is the neurodegeneration of retinal ganglion cells (RGCs) as they leave the eye at the optic nerve head (ONH). This neurodegeneration has diverse and complex mechanisms. One of the most famous mechanisms, which lead to damage in RGCs, are including the following:
The elevation in the intraocular pressure (IOP)
There are many studies were established to normalize the intraocular pressure. However, there are some glaucomatous patients have normal intraocular pressure (which named as normal tension glaucoma (NTG) 13, 14 . In which destruction happens to the optic nerve deprived of eye, pressure above the normal level. This situation was complicated the developments of effective antiglaucamtous drugs 
Morphological Defect in the lamina cribrosa
Additional "mechanical" theory in the pathophysiology of glaucoma is concentrated on the lamina cribrosa 
Ocular effect of renin inhibitors
Renin is the circulating enzyme that converts the angiotensinogen, in the plasma to yield the decapeptide angiotensin 1. Ang 1 have weak vasoconstrictor action and it is fragmented by angiotensin-converting enzyme (ACE) to the more potent octapeptide Ang II 25, 26 .
In a recent study, the topical application of renin inhibitor (ssp 635) was produced significant decrease in the IOP in the laser- 8 References
